PubMed Health⌕ Search

PubMed · 12411562

An observer study evaluating dual-plane circular-orbit cone-beam brain SPECT.

Abstract

UNLABELLED: Dual-plane circular-orbit cone-beam (DPCB) SPECT uses a pair of dissimilar cone-beam collimators to expand the axial field of view for brain SPECT. We applied observer study methodology to evaluate the improvement in detection of small defects in brain perfusion provided by DPCB SPECT, compared with conventional parallel-beam imaging. We also evaluated the effect of changing the radius of rotation on DPCB imaging. METHODS: Images were realistically simulated using a brain phantom. High-count Monte Carlo simulations were performed for 4 imaging configurations: low-energy high-resolution parallel-beam imaging at a radius of rotation of 18 cm and DPCB imaging (52-cm focal length) at radii of rotation of 20, 24, and 28 cm. These distances corresponded to those required for our camera to clear the shoulders of a patient in the 5th, 50th, and 95th percentiles of shoulder width. Perfusion defects of approximately 1.8-cm diameter were simulated at 4 locations in the brain. Poisson noise was simulated, and images were reconstructed to create a set of 200 images for each of the 4 configurations. All reconstructions used ordered-subset expectation maximization with attenuation modeling. Eight observers viewed images on which the possible location of the defect was marked. The observers were trained using 384 images, were tested using 416 images, and rated on a continuous scale their confidence about the presence of a defect. RESULTS: Using a paired t test for the estimated areas under the receiver operating characteristic (ROC) curve for each observer, we found that all 3 DPCB configurations resulted in higher areas under the ROC curve than did the parallel-beam configuration. Further, area under the ROC curve for the DPCB configurations improved with decreasing radius of rotation. All comparisons were significant at P < 0.05, except for DPCB 20 cm to DPCB 24 cm (P = 0.089). CONCLUSION: Use of a dual-plane cone beam is feasible for brain SPECT and better detects small perfusion defects than does a parallel beam, despite the possibility that the radius of rotation will need to be increased significantly to clear the patient's shoulders. A dual-plane cone beam should be used with the shortest radius of rotation possible to maximize the detectability of small perfusion defects.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

David S Lalush, Andrew J DiMeo. 2002. An observer study evaluating dual-plane circular-orbit cone-beam brain SPECT.. https://pubmed.ncbi.nlm.nih.gov/12411562/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Background: DNA methylation profiling is a tool that provides key support for central nervous system (CNS) tumor classification. However, diagnostically ambiguous pediatric cases may result in discordant outputs across classifiers. We developed MAGIBU, a cross-platform, projection-based framework that embeds individual methylomes into a fixed CNS reference landscape, ranking diagnostic entities by local epigenetic proximity to support clinician-led integrative diagnosis. Methods: As a proof-of-concept, we evaluated MAGIBU in eight morphologically challenging pediatric/juvenile CNS tumors with unresolved diagnoses after institutional and central pathology review. To establish a benchmark in the absence of a definitive histopathological ground truth, a consensus epigenetic reference was defined a priori for cases showing concordant results between the Heidelberg CNS Tumor Methylation Classifier and Methylscape Analysis. Comparisons were also performed with Epigenomic Digital Pathology (EpiDiP). To validate MAGIBU beyond this discovery cohort, performance was assessed at the family level across the CNS methylation spectrum (n = 678, 28 methylation families), on non-array platforms (whole-genome bisulfite sequencing and Oxford Nanopore), and in a focused analysis of the low-grade glioma and diffuse midline glioma compartment across four independent cohorts (n = 670). Results: In the discovery cohort, MAGIBU achieved high concordance with the consensus reference (Cohen's &#x3ba; = 0.855), outperforming EpiDiP (&#x3ba; = 0.278), which frequently placed low-grade tumors in proximity to higher-grade reference regions. Conclusions: MAGIBU provides a stable, quantitative differential diagnosis framework that mitigates the limitations of rigid categorical assignments. By leveraging a distance-based proximity metric, it offers a transparent decision-support tool that integrates effectively with clinical, radiological, and molecular data. While performance is inherently dependent on reference atlas composition, MAGIBU represents a robust complementary approach for the diagnostic workup of ambiguous CNS tumors.

Brain↗

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.

Brain↗